As indicated by cell death assay, combinational treatment of PI with AUR markedly enhanced HCC cell death compared to monotherapy (Fig. 6A–C), recapitulating the sensitization phenotype observed in AUR/ChaC1 models. Here, CHAC1 is linked to hepatocellular carcinoma.